These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 20530669)

  • 1. High levels of Nrf2 determine chemoresistance in type II endometrial cancer.
    Jiang T; Chen N; Zhao F; Wang XJ; Kong B; Zheng W; Zhang DD
    Cancer Res; 2010 Jul; 70(13):5486-96. PubMed ID: 20530669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2.
    Wang XJ; Sun Z; Villeneuve NF; Zhang S; Zhao F; Li Y; Chen W; Yi X; Zheng W; Wondrak GT; Wong PK; Zhang DD
    Carcinogenesis; 2008 Jun; 29(6):1235-43. PubMed ID: 18413364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nrf2 expression in endometrial serous carcinomas and its precancers.
    Chen N; Yi X; Abushahin N; Pang S; Zhang D; Kong B; Zheng W
    Int J Clin Exp Pathol; 2010 Dec; 4(1):85-96. PubMed ID: 21228930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNAi-mediated silencing of nuclear factor erythroid-2-related factor 2 gene expression in non-small cell lung cancer inhibits tumor growth and increases efficacy of chemotherapy.
    Singh A; Boldin-Adamsky S; Thimmulappa RK; Rath SK; Ashush H; Coulter J; Blackford A; Goodman SN; Bunz F; Watson WH; Gabrielson E; Feinstein E; Biswal S
    Cancer Res; 2008 Oct; 68(19):7975-84. PubMed ID: 18829555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Putative chemopreventive molecules can increase Nrf2-regulated cell defense in some human cancer cell lines, resulting in resistance to common cytotoxic therapies.
    Hu L; Miao W; Loignon M; Kandouz M; Batist G
    Cancer Chemother Pharmacol; 2010 Aug; 66(3):467-74. PubMed ID: 19940992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism.
    Ren D; Villeneuve NF; Jiang T; Wu T; Lau A; Toppin HA; Zhang DD
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1433-8. PubMed ID: 21205897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
    Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
    PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
    Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LAT1 is a putative therapeutic target in endometrioid endometrial carcinoma.
    Marshall AD; van Geldermalsen M; Otte NJ; Anderson LA; Lum T; Vellozzi MA; Zhang BK; Thoeng A; Wang Q; Rasko JE; Holst J
    Int J Cancer; 2016 Dec; 139(11):2529-39. PubMed ID: 27486861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
    Singh A; Misra V; Thimmulappa RK; Lee H; Ames S; Hoque MO; Herman JG; Baylin SB; Sidransky D; Gabrielson E; Brock MV; Biswal S
    PLoS Med; 2006 Oct; 3(10):e420. PubMed ID: 17020408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SQ1274, a novel microtubule inhibitor, inhibits ovarian and uterine cancer cell growth.
    Mills KA; Roach ST; Quinn JM; Guo L; Beck HM; Lomonosova E; Ilivicky AR; Starks CM; Lawrence JA; Hagemann AR; McCourt C; Thaker PH; Powell MA; Mutch DG; Fuh KC
    Gynecol Oncol; 2018 Nov; 151(2):337-344. PubMed ID: 30190114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
    Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
    Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The emerging role of the Nrf2-Keap1 signaling pathway in cancer.
    Jaramillo MC; Zhang DD
    Genes Dev; 2013 Oct; 27(20):2179-91. PubMed ID: 24142871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effects of Cannabidiol and Prognostic Role of TRPV2 in Human Endometrial Cancer.
    Marinelli O; Morelli MB; Annibali D; Aguzzi C; Zeppa L; Tuyaerts S; Amantini C; Amant F; Ferretti B; Maggi F; Santoni G; Nabissi M
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional dissection of Nrf2-dependent phase II genes in vascular inflammation and endotoxic injury using Keap1 siRNA.
    Kim JH; Choi YK; Lee KS; Cho DH; Baek YY; Lee DK; Ha KS; Choe J; Won MH; Jeoung D; Lee H; Kwon YG; Kim YM
    Free Radic Biol Med; 2012 Aug; 53(3):629-40. PubMed ID: 22609006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer.
    Shibata T; Kokubu A; Gotoh M; Ojima H; Ohta T; Yamamoto M; Hirohashi S
    Gastroenterology; 2008 Oct; 135(4):1358-1368, 1368.e1-4. PubMed ID: 18692501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of keap1 and nrf2 genetic mutations and polymorphisms with endometrioid endometrial adenocarcinoma survival.
    Wong TF; Yoshinaga K; Monma Y; Ito K; Niikura H; Nagase S; Yamamoto M; Yaegashi N
    Int J Gynecol Cancer; 2011 Nov; 21(8):1428-35. PubMed ID: 21897267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.